LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 25 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,247,353 | +2.1% | 1,256,000 | 0.0% | 1.18% | -13.2% |
| Q4 2022 | $1,222,245 | +0.3% | 1,256,000 | 0.0% | 1.36% | -14.5% |
| Q3 2022 | $1,219,000 | +4.7% | 1,256,000 | +3.5% | 1.60% | +1.7% |
| Q2 2022 | $1,164,000 | -0.9% | 1,214,000 | +0.8% | 1.57% | +15.2% |
| Q1 2022 | $1,174,000 | +45.7% | 1,204,000 | +148542.0% | 1.36% | +57.6% |
| Q4 2021 | $806,000 | +0.5% | 810 | 0.0% | 0.86% | -31.9% |
| Q3 2021 | $802,000 | +0.1% | 810 | 0.0% | 1.27% | +26.7% |
| Q2 2021 | $801,000 | +88.9% | 810 | -99.8% | 1.00% | +109.0% |
| Q1 2021 | $424,000 | -32.3% | 410,000 | -38.3% | 0.48% | -13.4% |
| Q4 2020 | $626,000 | +12.8% | 665,000 | +8.1% | 0.55% | -29.4% |
| Q3 2020 | $555,000 | – | 615,000 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |